| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |